Showing results (161-170 of 319) with videos related to

Sort By:
Pageof 32
Biomarker Research|May 22, 2018
Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutationIsaac Ks Ng, Joanne Lee, Christopher Ng, et al.
Journal of Clinical Pathology|January 20, 2017
Clinical implications of DNMT3A mutations in a Southeast Asian cohort of acute myeloid leukaemia patientsMarcus Tan, Isaac K S Ng, Zhaojin Chen, et al.
Genome Biology|August 17, 2021
Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequencesFan Cao, Yu Zhang, Yichao Cai, et al.
Nature Communications|September 1, 2025
Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activationKamalakshi Deka, Jean-Michel Carter, Akash Bahai, et al.
The Journal of Pathology|February 5, 2011
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingSiok-Bian Ng, Viknesvaran Selvarajan, Gaofeng Huang, et al.
Blood|September 17, 2011
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaSiok-Bian Ng, Junli Yan, Gaofeng Huang, et al.
American Journal of Hematology|May 30, 2012
Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study GroupEric Tse, Harinder Gill, Florence Loong, et al.
Genome Biology|March 5, 2020
NanoVar: accurate characterization of patients' genomic structural variants using low-depth nanopore sequencingCheng Yong Tham, Roberto Tirado-Magallanes, Yufen Goh, et al.
Blood Cancer Journal|February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportDavid L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Advances in Therapy|June 12, 2020
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup AnalysisShang-Yi Huang, Sung-Soo Yoon, Kazuyuki Shimizu, et al.
Pageof 32